Navigation Links
ThermoGenesis Announces Distribution Agreement for Bone Marrow Stem Cell Device
Date:9/9/2008

inties that could cause actual outcomes to differ materially from those contemplated by the forward-looking statements. Several factors, including timing of FDA approvals, changes in customer forecasts, our failure to meet customers' purchase order and quality requirements, supply shortages, production delays, changes in the markets for customers' products, introduction timing and acceptance of our new products scheduled for fiscal year 2009, and introduction of competitive products and other factors beyond our control, could result in a materially different revenue outcome and/or in our failure to achieve the revenue levels we expect for fiscal 2009. A more complete description of these and other risks that could cause actual events to differ from the outcomes predicted by our forward-looking statements is set forth under the caption "Risk Factors" in our annual report on Form 10-K and other reports we file with the Securities and Exchange Commission from time to time, and you should consider each of those factors when evaluating the forward-looking statements.

ThermoGenesis Corp.

Web site: http://www.thermogenesis.com

Contact: Investor Relations

+1-916-858-5107, or

ir@thermogenesis.com


'/>"/>
SOURCE ThermoGenesis Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent
2. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal 2008 on September 9, 2008
3. ThermoGenesis Names Tiffany Olson to Board of Directors
4. ThermoGenesis Announces FDA Authorization to Market MarrowXpress(TM) (MXP(TM))
5. ThermoGenesis Announces Receipt of CE Mark for MarrowXpress(TM)
6. ThermoGenesis Names Dr. Mahendra Rao to Board of Directors
7. ThermoGenesis Subsidiary Vantus Announces Stem Cell Agreement With UC Davis Center For Equine Health
8. ThermoGenesis Corp. Announces Voluntary Recall of Selected Lots of AXP Bag Sets
9. ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
10. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2008 Results on February 6, 2008
11. ThermoGenesis Corp. to Announce First Quarter Fiscal 2008 Results on November 8, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):Charles Darwin: More than the origin 2Charles Darwin: More than the origin 3Oceans day at International Climate Change Conference 2Masimo and Oridion Sign Connectivity Agreement to Integrate Capnostream 28TM 2920 Portable Bedside Monitors into the Masimo Patient SafetyNet 28TM 29 54210 1Masimo and Oridion Sign Connectivity Agreement to Integrate Capnostream 28TM 2920 Portable Bedside Monitors into the Masimo Patient SafetyNet 28TM 29 54210 2Masimo and Oridion Sign Connectivity Agreement to Integrate Capnostream 28TM 2920 Portable Bedside Monitors into the Masimo Patient SafetyNet 28TM 29 54210 3Masimo and Oridion Sign Connectivity Agreement to Integrate Capnostream 28TM 2920 Portable Bedside Monitors into the Masimo Patient SafetyNet 28TM 29 54210 4Masimo and Oridion Sign Connectivity Agreement to Integrate Capnostream 28TM 2920 Portable Bedside Monitors into the Masimo Patient SafetyNet 28TM 29 54210 5Masimo and Oridion Sign Connectivity Agreement to Integrate Capnostream 28TM 2920 Portable Bedside Monitors into the Masimo Patient SafetyNet 28TM 29 54210 6HDM Offers Solution to Health Care Fraud Cited by CNN and Health Plan Week 54205 1HDM Offers Solution to Health Care Fraud Cited by CNN and Health Plan Week 54205 2Plasma Protein Therapeutics Association Urges CMS For Appropriate Hospital Outpatient Drug Reimbursement 54200 1Plasma Protein Therapeutics Association Urges CMS For Appropriate Hospital Outpatient Drug Reimbursement 54200 2Plasma Protein Therapeutics Association Urges CMS For Appropriate Hospital Outpatient Drug Reimbursement 54200 3